Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs

Racheli Ofir of Betalin Therapeutics

18 min · 31. mai 2026
Forsidebilde av episoden Racheli Ofir of Betalin Therapeutics

Beskrivelse

Racheli Ofir is the CEO and CTO of Betalin Therapeutics, an Israeli company developing a biological micropancreas that could one day offer a one-time cure for insulin-dependent diabetes — replacing the missing pancreatic function with living cells that sense glucose and respond in real time. Avraham sat down with Racheli to discuss how the technology works, what their animal trials showed, why IP is critical, the challenges of funding a biotech startup in wartime Israel, her advice for founders just getting started and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/ betalin. Listen to all of the episodes at https://jmbdavis.com/podcast.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

60 Episoder

Forsidebilde av episoden Gilad Luria of Scenera

Gilad Luria of Scenera

Gilad Luria is the CEO of Scenera sceneratech.com, an Israeli deep tech company solving a critical blind spot in advanced chip manufacturing. As chipmakers stack layers of silicon to pack in more power, billions of tiny connections link those layers together, and until now, there was no way to check that all of them actually work. Scenera's technology inspects every single one, catching defects that would otherwise make it all the way to a finished device. Avraham sat down with Gilad to discuss how the idea and technology evolved to fit the right problem, the challenges of building a deep tech startup in Israel, the importance of IP strategy, his advice for founders just starting out and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/ scenera. Listen to all of the episodes at https://jmbdavis.com/podcast.

28. juli 202623 min
Forsidebilde av episoden Ofer Barshem of CellLipo

Ofer Barshem of CellLipo

Ofer Barshem is the Co-Founder and CEO of CellLipo, an Israeli medtech company developing a breakthrough technology that transforms a patient's own fat into a stem cell-rich therapy for regenerative medicine. The technology has the potential to make regenerative treatments more consistent, accessible, and ready for immediate use in both aesthetic and orthopedic medicine. Avraham sat down with Ofer to discuss the future of regenerative medicine, how CellLipo's technology works, the journey from hospital innovation to startup, fundraising challenges, the Israeli biotech ecosystem, the company's roadmap to clinical trials and FDA approval, tips for founders, and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/ cell-lipo. Listen to all of the episodes at https://jmbdavis.com/podcast.

29. juni 202622 min
Forsidebilde av episoden Racheli Ofir of Betalin Therapeutics

Racheli Ofir of Betalin Therapeutics

Racheli Ofir is the CEO and CTO of Betalin Therapeutics, an Israeli company developing a biological micropancreas that could one day offer a one-time cure for insulin-dependent diabetes — replacing the missing pancreatic function with living cells that sense glucose and respond in real time. Avraham sat down with Racheli to discuss how the technology works, what their animal trials showed, why IP is critical, the challenges of funding a biotech startup in wartime Israel, her advice for founders just getting started and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/ betalin. Listen to all of the episodes at https://jmbdavis.com/podcast.

31. mai 202618 min
Forsidebilde av episoden Chen Neeman of Enqode

Chen Neeman of Enqode

Chen Neeman is the Co-Founder and CEO of Enqode, an Israeli startup that protects company databases from quantum computing attacks—wrapping them in three layers of post-quantum encryption to achieve what they call "data immunity." Their system requires no downtime, no special expertise, and is built for any business that holds sensitive data. Avraham sat down with Chen to discuss the quantum threat, why companies need to start protecting themselves today, how Enqode works, the team behind it, their funding and their ambition to become a unicorn protecting billions of businesses worldwide. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/ enqode. Listen to all of the episodes at https://jmbdavis.com/podcast.

30. april 202616 min